Cincinnati, OH, United States of America

Gary Robert Kelm

This inventor holds 21 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: The Procter Gamble Company, Crescita Therapeutics Inc., Other. Active years: 1983-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Robert Kelm. Retrieved from https://idiyas.com/inventor/gary-robert-kelm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 90.5

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 927(Granted Patents)

Location History:

Mason, OH (US) (1997)
Cincinnati, OH (US) (1983 - 2021)

Company Filing History:

19 out of 17,173

The Procter Gamble Company

patents

1 out of 9

Crescita Therapeutics Inc.

patents

1 out of 834,513

Other

patents

Years Active: 1983-2021

Loading Chart...

Areas of Expertise:

Rinse-Off Compositions

Gastrointestinal Effects

Body Weight Management

Enteric Polymer Coatings

Ketorolac Treatment

Oral Diseases

Flavone Derivatives

Tebufelone Compositions

Antiperspirant Compositions

Skin Conditioning

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10945952 - Rinse-off compositions and uses thereof for delivery of active agents (2021-03-16),

2. 8372430 - Compositions, methods, and kits useful for the alleviation of gastrointestinal effects (2013-02-12),

3. 8287898 - Compositions and methods for body weight management (2012-10-16),

4. 7025984 - Compositions and methods for body weight management (2006-04-11),

5. 5914132 - Pharmaceutical dosage form with multiple enteric polymer coatings for (1999-06-22),

6. 5843479 - Bisacodyl dosage form with multiple enteric polymer coatings for colonic (1998-12-01),

7. 5814336 - Pharmaceutical dosage form for colonic delivery (1998-09-29),

8. 5785951 - Use of ketorolac for treatment of oral diseases and conditions (1998-07-28),

9. 5686106 - Pharmaceutical dosage form for colonic delivery (1997-11-11),

10. 5686105 - Pharmaceutical dosage form with multiple enteric polymer coatings for (1997-11-11),

11. 5670158 - Bisacodyl dosage form (1997-09-23),

12. 5656290 - Bisacodyl dosage form with multiple enteric polymer coatings for colonic (1997-08-12),

13. 5651983 - Bisacodyl dosage form for colonic delivery (1997-07-29),

14. 5646174 - Use of ketorolac for treatment of oral diseases and conditions (1997-07-08),

15. 5464609 - Use of ketorolac for treatment of oral diseases and conditions (1995-11-07),

Title: Gary Robert Kelm: A Prolific Inventor Contributing to Innovations in Healthcare and Personal Care

Introduction:

In the realm of innovations and patents, Gary Robert Kelm has made significant contributions to the fields of healthcare and personal care. With a strong background in invention, Kelm hails from Cincinnati, OH (US) and has an impressive portfolio of 20 patents to his name. His latest patents focus on rinse-off compositions for the delivery of active agents and methods for alleviating gastrointestinal effects. Let's delve into Kelm's latest achievements and explore his notable career highlights and collaborations.

Latest Patents:

Kelm's most recent patents showcase his expertise in developing rinse-off compositions for delivering active agents. These compositions contain an oil phase and an aqueous surfactant matrix, with active agents dissolved in non-polar, water-immiscible solvents. The innovative formulas can be used topically for treating conditions such as dermatitis and psoriasis. Some embodiments of these patents include the creation of specialized shampoo compositions that offer unique benefits to hair and scalp health.

In addition to his advancements in rinse-off compositions, Kelm has also patented inventions related to the alleviation of gastrointestinal effects. These inventions address conditions like gastrointestinal distress, obesity, hyperlipidemia, and Type II diabetes. The disclosed compositions can effectively reduce levels of toxic substances, blood cholesterol levels, and induce satiety. Notably, Kelm's inventions feature stiffening agents for lipophilic substances in the gastrointestinal tract, which contribute to their unique therapeutic properties.

Career Highlights:

Kelm's career highlights exemplify his dedication to innovation and his contributions to companies in the healthcare and personal care industries. He has honed his skills while working with esteemed organizations such as The Procter & Gamble Company and Crescita Therapeutics Inc. (Crescita). These companies have been at the forefront of cutting-edge research and development, making them ideal platforms for Kelm's inventive expertise.

Collaborations:

Throughout his journey as an inventor, Kelm has actively collaborated with various individuals to bring his ideas to life. Notable among his coworkers are Gary Lee Manring and Douglas Joseph Dobrozsi. These collaborations have helped foster an environment of knowledge sharing and teamwork, ultimately resulting in the development of groundbreaking inventions and patents.

Conclusion:

Gary Robert Kelm is an accomplished inventor whose contributions have significantly impacted the fields of healthcare and personal care. Through his latest patents, Kelm has demonstrated his prowess in developing unique rinse-off compositions and methods for alleviating gastrointestinal effects, addressing key challenges in these areas. With an extensive career and collaborations with experienced professionals, Kelm continues to drive innovation, advancing the frontiers of science and shaping the future of healthcare and personal care industries.

Profile summary based on public USPTO records.